Pfizer to buy two Baxter vaccines for $635 mln

July 30 (Reuters) - Pfizer Inc agreed to buy two of Baxter International Inc's vaccines and a part of a facility involved in their production for $635 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.